Skip to main content
Caplight Logo









Medicinal Genomics

Medicinal Genomics

Private
Beverly, MassachusettsHealthcare & Life Scienceshttps://medicinalgenomics.com/

Last Round

Series A

Apr 6, 2021

Total Funding Raised

$13.31M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Medicinal Genomics is a biotechnology company that provides genomic services, including microbial and plant pathogen testing, for the cannabis, hemp, and natural products industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Compliance

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

cannabis testinggenomic sequencingpathogen detectionqPCRcannabis compliancemolecular diagnosticscannabis labDNA extractionbioinformaticsstrain identificationquality controlcannabis analyticsweed testingmicrobial testingcannabis genetics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medicinal Genomics Comparables

Compare Medicinal Genomics with similar companies based on industry and business-model similarity.

Medicinal Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phylos Bioscience
87%
Segra International
77%
SC Labs
73%

Medicinal Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 6, 2021
GrantJan 26, 2017
Growth EquityJul 14, 2015
Early FundingOct 18, 2011

Medicinal Genomics Investors

Notable investors and investment history

Medicinal Genomics investors
InvestorRounds
National Institute on Drug AbuseGrant
First AnalysisSeries A
Bunker Hill CapitalGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 50% MoM.

  • Apr 6, 2021

    $5M round led by First Analysis

Medicinal Genomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Medicinal Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medicinal Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeverly, Massachusetts
Employee Range26
Year Founded2011
Last FundingApr 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?